Taking a Second Look at Trademark License Agreements in Light of Mission Product Holdings Inc. v. Tempnology, LLC – Part II

Taking a Second Look at Trademark License Agreements in Light of Mission Product Holdings Inc. v. Tempnology, LLC – Part II by Gloria Steinberg Back in February of this year, the U.S. Supreme Court heard the oral argument for Mission Product Holdings Inc. v. Tempnology, LLC, to determine “[w]hether, under Section 365 of the Bankruptcy Code, a debtor-licensor’s ‘rejection’ of …

Convertible Promissory Note Financing: Part I – Introduction

Convertible Promissory Note Financing: Part I – Introduction by Shamim Mohandessi This series explores the convertible promissory note (referred to in this article series as a “convertible note”). A convertible note is an instrument frequently used by startup companies to: (1) finance early growth activities, before the formation of capital through the offering of priced equity, or (2) bridge financing, …

Hopeful Prospects for Clarity in Section 101 of the Patent Act

Hopeful Prospects for Clarity in Section 101 of the Patent Act by Nabil Abdalla Since the U.S. Supreme Court decision in Alice Corp. Pty. Ltd. v. CLS Bank Intl, USPTO examiners, inventors, and patent practitioners, alike, have been navigating through a “sometimes murky” understanding of subject matter eligibility. In an attempt to provide clarity and predictability, the USPTO has released …

Taking a Second Look at Trademark License Agreements in Light of Mission Product Holdings Inc. v. Tempnology, LLC – Part I

Taking a Second Look at Trademark License Agreements in Light of Mission Product Holdings Inc. v. Tempnology, LLC – Part I by Gloria Steinberg On February 20, the U.S. Supreme Court heard the oral argument for Mission Product Holdings Inc. v. Tempnology, LLC, to determine “[w]hether, under Section 365 of the Bankruptcy Code, a debtor-licensor’s ‘rejection’ of a license agreement …

Supreme Court Affirms Interpretation of “On-Sale Bar” in Helsinn Healthcare S. A. v. Teva Pharmaceuticals US, Inc.

Supreme Court Affirms Interpretation of “On-Sale Bar” in Helsinn Healthcare S. A. v. Teva Pharmaceuticals US, Inc. by Shamim Mohandessi On January 22, the US Supreme Court, on Writ Certiorari to the US Court of Appeals for the Federal District held that under the Leahy-Smith American Invents Act (“AIA”), “a commercial sale to a third party who is required to …